Medical Devices APAC

APAC Neurovascular Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Neurovascular Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $751.8 Mn Placeholder estimate
Estimate 2025 $820.2 Mn 18.5% of the global market
Projected 2034 $1.80 Bn 119% Adds $976.0 Mn over 9 forecast years
CAGR 2025–2034 9.1% Faster than 42% of 173 Medical Devices markets here
Key players 5
  • APAC is 18.51% of the global market.
  • Among regions, the largest is North America at $2.00 Bn.
  • Fastest growing: APAC (this report) at 9.1% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$976.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Neurovascular Devices Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $751.8 Mn — —
2025 (base) $820.2 Mn +$68.4 Mn —
2026 (forecast) $894.9 Mn +$74.6 Mn +9.1%
2027 (forecast) $976.3 Mn +$81.4 Mn +19%
2028 (forecast) $1.07 Bn +$88.8 Mn +29.9%
2029 (forecast) $1.16 Bn +$96.9 Mn +41.7%
2030 (forecast) $1.27 Bn +$105.7 Mn +54.6%
2031 (forecast) $1.38 Bn +$115.4 Mn +68.6%
2032 (forecast) $1.51 Bn +$125.9 Mn +84%
2033 (forecast) $1.65 Bn +$137.3 Mn +100.7%
2034 (forecast) $1.80 Bn +$149.8 Mn +119%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Neurovascular Devices Market Analysis at a glance
Market size, 2025$820.2 Mn placeholder estimate
Forecast, 2034$1.80 Bn placeholder estimate
Growth (CAGR), 2025–20349.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, condition and end user (see all)
Key playersStryker, Medtronic, Penumbra, Johnson & Johnson, MicroVention (Terumo) (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Neurovascular Devices Market Analysis Executive Summary

Neurovascular devices treat stroke and brain aneurysms through catheters, using clot-removal devices, coils, stents and flow diverters.

Key segments of the neurovascular Devices market include product (Stent Retrievers, Aspiration Catheters and Embolic Coils) and condition (Ischemic Stroke, Brain Aneurysm and AV Malformations).

Bar chart: Asia Pacific Neurovascular Devices market size, 2024–2034, placeholder estimates. $751.8 Mn in 2024, $820.2 Mn in 2025 and $1.80 Bn in 2034, 9.1% CAGR.
Asia Pacific Neurovascular Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Neurovascular Devices Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurovascular Devices market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the neurovascular Devices market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the neurovascular Devices market.

Competitive Landscape for Neurovascular Devices Market in APAC

The neurovascular Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Neurovascular Devices Market in APAC

Neurovascular Devices in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[11], basic medical insurance (China)⁠[12], the Hospital Authority (Hong Kong)⁠[13], Ayushman Bharat PM-JAY (India)⁠[14], public health insurance (Japan)⁠[15], subsidised public care (Malaysia)⁠[16], Pharmac (New Zealand)⁠[17], PhilHealth (Philippines)⁠[18], MediShield Life (Singapore)⁠[19] and the Universal Coverage Scheme (Thailand)⁠[20].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[12] National Healthcare Security Administration. Checked 14 Nov 2026.

[13] Hospital Authority. Checked 14 Nov 2026.

[14] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[15] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[16] Ministry of Health Malaysia. Checked 14 Nov 2026.

[17] Pharmac. Checked 14 Nov 2026.

[18] PhilHealth. Checked 14 Nov 2026.

[19] CPF Board, MediShield Life. Checked 14 Nov 2026.

[20] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurovascular Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Neurovascular Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Neurovascular Devices in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Neurovascular Devices market in Asia Pacific?
Placeholder estimate: about $820.2 Mn in 2025, rising to about $1.80 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Neurovascular Devices market in Asia Pacific growing?
Placeholder estimate: about 9.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Neurovascular Devices market report cover?
The report splits the market by product (Stent Retrievers, Aspiration Catheters, Embolic Coils, Flow Diverters), condition (Ischemic Stroke, Brain Aneurysm, AV Malformations) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Neurovascular Devices market?
Key players include Stryker, Medtronic, Penumbra, Johnson & Johnson and MicroVention (Terumo).
What is driving the Neurovascular Devices market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurovascular Devices market.
How much research is published on Neurovascular Devices?
PubMed lists 19 papers on Neurovascular Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on brain and nerves and stroke

See the topic